Reovirus

From WikiMD's WELLNESSPEDIA

Reovirus is a genus of double-stranded RNA viruses in the family Reoviridae. The name "reovirus" is derived from respiratory enteric orphan virus, reflecting the fact that the virus is not associated with any known disease, and it was isolated from the respiratory and enteric systems. Reoviruses are non-enveloped and have an icosahedral capsid.

Structure[edit]

Reoviruses have a double-layered capsid and a genome consisting of 10-12 segments of double-stranded RNA. The outer capsid is removed in the host cell's cytoplasm, leaving the inner capsid to carry out transcription and replication.

Replication[edit]

Reoviruses replicate in the cytoplasm of the host cell. The virus enters the cell through receptor-mediated endocytosis. The outer capsid is removed, and the inner capsid carries out transcription and replication. The newly synthesized viral proteins and genomes are assembled into new virions in the cytoplasm.

Pathogenesis[edit]

Although reoviruses are not typically associated with disease, they can cause mild respiratory and gastrointestinal symptoms in humans. In animals, reoviruses can cause severe disease, including fatal encephalitis in mice and respiratory disease in birds.

Research[edit]

Reoviruses are used extensively in research because they are easy to grow in the lab and their replication cycle is well understood. They are also being investigated as potential oncolytic agents, as they can selectively kill cancer cells.

See also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.